We are on a mission to protect the world from cardiovascular disease
Scroll to discover
Cardiovascular disease (CVD) is the #1 cause of death worldwide despite available treatments.
One person dies every 34 seconds from CVD in the U.S.
There are approximately 800,000 heart attacks each year in the U.S.
Hundreds of millions of people are living with atherosclerotic cardiovascular disease (ASCVD), a subset of CVD, worldwide.
Verve is meeting this challenge head-on through the development of groundbreaking, single-course gene editing medicines.
Verve at a Glance
Heart is at the center of everything we do
Cardiovascular disease (CVD) is the leading cause of death, directly impacting hundreds of millions of people worldwide. Verve is on a mission to protect the world from CVD.
Verve is advancing a pipeline of single-course in vivo gene editing programs intended to safely inactivate genes in the liver that contribute to CVD risk.